House Oversight Committee Chair Comer: FDA Must Provide Americans Guidance on CBD Products
April 18, 2023
April 18, 2023
WASHINGTON, April 18 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release:
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) is investigating the Food and Drug Administration's (FDA) failure to regulate cannabidiols (CBD) products as dietary supplements. In a letter to the Commissioner of Food and Drugs at the FDA, Dr. Robert M. Califf, Chairman Comer raises concern that the a . . .
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) is investigating the Food and Drug Administration's (FDA) failure to regulate cannabidiols (CBD) products as dietary supplements. In a letter to the Commissioner of Food and Drugs at the FDA, Dr. Robert M. Califf, Chairman Comer raises concern that the a . . .